Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nervgen Pharma Corp (NGENF)

Nervgen Pharma Corp (NGENF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade NGENF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.8400 +10.33%
on 09/12/24
2.2542 -9.95%
on 08/29/24
-0.1700 (-7.73%)
since 08/16/24
3-Month
1.6300 +24.54%
on 06/21/24
2.4200 -16.12%
on 07/05/24
+0.3700 (+22.29%)
since 06/18/24
52-Week
1.1600 +75.00%
on 12/14/23
2.9900 -32.11%
on 02/08/24
+0.4800 (+30.97%)
since 09/18/23

Most Recent Stories

More News
NervGen Pharma to Present at the 63rd International Spinal Cord Society Annual Scientific Meeting

Vancouver, British Columbia--(Newsfile Corp. - September 16, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma Reports Q2 2024 Financial Results and Operational Updates

Targeting to complete enrollment in the Phase 1b/2a chronic cohort in Q3 2024Protocol being amended to enhance enrollment and lessen burden on participants in the subacute cohortNVG-300 advanced into preclinical...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference

Vancouver, British Columbia--(Newsfile Corp. - August 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma Grants Stock Options

Vancouver, British Columbia--(Newsfile Corp. - August 2, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) a clinical stage biotech company dedicated to developing innovative solutions for the treatment...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma Appoints Neil Klompas to Board of Directors

Seasoned pharmaceutical executive with extensive experience in high-growth life sciences companies joins NervGenLeadership appointment supports the company's mission to advance NVG-291 after the completion...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage

New molecule demonstrates efficacy in a challenging SCI modelExpanding pipeline into new indications of ischemic stroke and ALSVancouver, British Columbia--(Newsfile Corp. - June 25, 2024) - NervGen Pharma...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium

Vancouver, British Columbia--(Newsfile Corp. - June 20, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma Grants Stock Options

Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) a clinical-stage biotech company dedicated to developing innovative solutions for the treatment...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)
NervGen Pharma Announces Results of Annual General Meeting of Shareholders

All resolutions submitted for approval were passed by shareholdersGlenn Ives appointed as Chair of the BoardJohn Ruffolo appointed as Chair of the Audit CommitteeVancouver, British Columbia--(Newsfile...

NGENF : 2.0300 (+1.50%)
NGEN.VN : 2.750 (+1.48%)

Key Turning Points

3rd Resistance Point 2.1200
2nd Resistance Point 2.0900
1st Resistance Point 2.0600
Last Price 2.0300
1st Support Level 2.0000
2nd Support Level 1.9700
3rd Support Level 1.9400

See More

52-Week High 2.9900
Fibonacci 61.8% 2.2909
Fibonacci 50% 2.0750
Last Price 2.0300
Fibonacci 38.2% 1.8591
52-Week Low 1.1600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar